Sudhanshu Mulay, MD
DownloadHi-Res Photo
About
Titles
Adjunct Assistant Professor
Biography
Dr. Mulay received his medical degree from BJ Medical College, Pune, India. He completed his internal medicine residencies at Michael Reese Hospital, Chicago, Illinois, as well as the University of Connecticut School of Medicine, Farmington.
Dr. Mulay also completed two fellowships; one in hematology/oncology at the University of Connecticut School of Medicine, and one in transfusion medicine at the Mayo Clinic, Rochester, Minnesota.
Dr. Mulay holds memberships at the American Society of Clinical Oncology, the American Society of Hematology, and the International Society on Thrombosis and Haemostasis.
Appointments
Medical Oncology
Assistant Professor AdjunctPrimary
Other Departments & Organizations
Education & Training
- MD
- BJ Medical College (2004)
Research
Clinical Trials
Current Trials
Phase 2 Study of Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory CD30 Positive T-cell Lymphoma
HIC ID2000029793RoleSub InvestigatorPrimary Completion Date02/01/2023Recruiting ParticipantsAn Open-Label, Dose Escalation and Dose Expansion Trial Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of Orally Administered CA-4948 in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
HIC ID2000022049RoleSub InvestigatorPrimary Completion Date08/31/2026Recruiting ParticipantsA Phase 3, Randomized, Multicenter, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Birtamimab Plus Standard of Care vs. Placebo Plus Standard of Care in Mayo Stage IV Subjects With Light Chain (AL) Amyloidosis
HIC ID2000030933RoleSub InvestigatorPrimary Completion Date06/30/2024Recruiting ParticipantsNovel Combination of Belantamab Mafodotin and Elotuzumab to Enhance Therapeutic Efficacy in Multiple Myeloma
HIC ID2000028918RoleSub InvestigatorPrimary Completion Date01/01/2025Recruiting ParticipantsA Randomized, Phase IIB, Multicenter, Trial of Oral Azacytidine Plus Romidepsin Versus Investigator's Choice in Patients With Relapse or Refractory Peripheral T-cell Lymphoma (PTCL)
HIC ID2000030190RoleSub InvestigatorPrimary Completion Date06/02/2026Recruiting Participants
Get In Touch
Contacts
Events
Sep 202413-14Multiple Days
Everyone Multi-session EventAmer Zeidan, MBBS - Sudhanshu Mulay, MD